KRONOX — Kronox Lab Sciences Cashflow Statement
0.000.00%
- IN₹6.41bn
- IN₹6.04bn
- IN₹1.00bn
- 82
- 18
- 49
- 49
Annual cashflow statement for Kronox Lab Sciences, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | R2023 March 31st | 2024 March 31st | 2025 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | ARS | ARS | PRESS |
Standards: | IAS | IAS | IAS | IAS | — |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 132 | 184 | 220 | 286 | 343 |
Depreciation | |||||
Non-Cash Items | 2.16 | 3.05 | -3.21 | -7.52 | -15.1 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -41 | -117 | -35.5 | -117 | -34.5 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 113 | 90.2 | 197 | 174 | 307 |
Capital Expenditures | -16.5 | -38 | -84.1 | -123 | -31 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | -13.1 | -38 | 18.2 | -50.4 | -253 |
Sale of Fixed Assets | |||||
Change in Net Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -29.6 | -76 | -66 | -173 | -284 |
Financing Cash Flow Items | -12 | -12.9 | -8.95 | 0 | — |
Other Financing Cash Flow | |||||
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -71 | -6.66 | -134 | 0 | -18.5 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 12.6 | 7.56 | -3.26 | 1.03 | 4.49 |